Stock listing

Xuanzhu Biopharmaceutical Co., Ltd. Class H

Selected listing: 2575 · HKEX · HKD · HK

Xuanzhu Biopharmaceutical Co., Ltd. Class H (HKEX:2575), Commercial Services. Latest release Jun 21, 2026: VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED…

2575:HKEXHKDHKUpdated October 2, 2026
Xuanzhu Biopharmaceutical Co., Ltd. Class H logo
Ticker
HKEX:2575
Asset type
Stock
Sector
Commercial Services
Industry
Miscellaneous Commercial Services
Exchange
HKEX
Currency
HKD

About Xuanzhu Biopharmaceutical Co., Ltd. Class H

The company focuses on biopharmaceutical development and innovation. Its commitment to advancing healthcare solutions positions it as a notable player in the industry.

Latest news from Xuanzhu Biopharmaceutical Co., Ltd. Class H

VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN PHASE III CLINICAL TRIAL OF ANAPRAZOLE SODIUM FOR HELICOBACTER PYLORI ERADICATION

June 21, 2026

LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

June 18, 2026

All Xuanzhu Biopharmaceutical Co., Ltd. Class H news →

Research Xuanzhu Biopharmaceutical Co., Ltd. Class H

Xuanzhu Biopharmaceutical Co., Ltd. Class H company profile

View the public company page for Xuanzhu Biopharmaceutical Co., Ltd. Class H on 6ix.

Xuanzhu Biopharmaceutical Co., Ltd. Class H news

Read company news and market updates connected to Xuanzhu Biopharmaceutical Co., Ltd. Class H.

Xuanzhu Biopharmaceutical Co., Ltd. Class H investor events

Find investor webinars, events, and replay context for Xuanzhu Biopharmaceutical Co., Ltd. Class H.

Alternate listings

V59:FWB

DE · EUR

Alternate listing for Xuanzhu Biopharmaceutical Co., Ltd. Class H; the primary context on this page is 2575:HKEX.